The objectives of this study were to measure the expression of PD-L1 and CD8 in patients with anal cancer treated with CRT, to correlate tumor PD-L1 and CD8 expression with OS and PFS, and to define a PD-L1 positivity cut-point best associated with OS using a highly accurate quantitative image analysis approach. This evidence concerns the gene CD8A and anal carcinoma.